Stable lipid-comprising drug delivery complexes and methods for their production
    31.
    发明授权
    Stable lipid-comprising drug delivery complexes and methods for their production 失效
    稳定的含脂质药物递送复合物及其生产方法

    公开(公告)号:US07655468B2

    公开(公告)日:2010-02-02

    申请号:US11943434

    申请日:2007-11-20

    IPC分类号: C12N15/88 A61K31/70 A61K9/127

    摘要: Novel stable, concentrated, biologically active and ready-to-use lipid-comprising drug delivery complexes and methods for their production are described. The biological activity of the complexes produced are comparable to the formulations prepared according to the prior art admixture method and upon purification, the complexes produced by the method of this invention are 50 to 500 fold more concentrated than the complexes formed by admixture. The method described herein provides for the large scale production of lipid-comprising drug delivery systems useful for gene therapy and other applications.

    摘要翻译: 描述了新的稳定的,浓缩的,生物活性的和即用型含脂质的药物递送复合物及其生产方法。 所生成的络合物的生物活性与根据现有技术的混合方法制备的制剂相当,并且在纯化后,通过本发明的方法制备的络合物比通过混合物形成的络合物浓度多50至500倍。 本文所述的方法提供大规模生产用于基因治疗和其它应用的含脂质药物递送系统。

    Emulsion formulations for hydrophilic active agents
    34.
    发明授权
    Emulsion formulations for hydrophilic active agents 失效
    亲水性活性剂的乳液制剂

    公开(公告)号:US06610321B2

    公开(公告)日:2003-08-26

    申请号:US09214546

    申请日:1999-02-17

    IPC分类号: A61K9127

    摘要: This invention includes emulsion formulations comprising an aqueous carrier and the following components: triglyceride, cholesterol, phospholipid, at least one charged lipid, at least one hydrophilic biologically active molecule and, optionally, cholesteryl ester, and/or apoprotein; methods of preparing these emulsions; and the use of these emulsions for the delivery of hydrophilic biologically active molecules to cells.

    摘要翻译: 本发明包括包含水性载体和以下组分的乳液制剂:甘油三酸酯,胆固醇,磷脂,至少一种带电脂质,至少一种亲水生物活性分子和任选的胆固醇酯和/或脱蛋白; 制备这些乳液的方法; 以及使用这些乳液将亲水生物活性分子递送至细胞。

    Acid salts of cholesterol
    35.
    发明授权
    Acid salts of cholesterol 失效
    胆固醇的酸性盐

    公开(公告)号:US06319516B1

    公开(公告)日:2001-11-20

    申请号:US09334313

    申请日:1999-06-16

    IPC分类号: A61K9127

    摘要: A stable aqueous dispersion which comprises a cationic lipid which is a molecule which comprises a cholesterol-derived lipophilic group, a linker bond which is hydrolyzable by cellular enzymes and relatively resistant to base-catalyzed hydrolysis, a spacer arm and a cationic amino group, and an appropriate co-lipid. The invention also includes the cationic lipids and mammalian plasmid DNA or other cells in admixture with the aqueous dispersion.

    摘要翻译: 一种稳定的水分散体,其包含阳离子脂质,其是包含胆固醇衍生的亲脂基团的分子,可被细胞酶水解并且相对抗碱基催化水解的连接体键,间隔臂和阳离子氨基,以及 合适的辅助脂质。 本发明还包括与水分散体混合的阳离子脂质和哺乳动物质粒DNA或其它细胞。

    Cationic cholesteryl derivatives containing cyclic polar groups
    36.
    发明授权
    Cationic cholesteryl derivatives containing cyclic polar groups 失效
    含有环状极性基团的阳离子胆固醇衍生物

    公开(公告)号:US06258792B1

    公开(公告)日:2001-07-10

    申请号:US09669031

    申请日:2000-09-25

    IPC分类号: A01N4304

    CPC分类号: C07J43/00 C07J53/00

    摘要: The present invention discloses compounds which are cationic cholesteryl derivatives having a nitrogen-containing ring structure as their polar head group. These compounds are useful for delivering biologically active substances to cells and for transfecting nucleic acids into cells.

    摘要翻译: 本发明公开了具有含氮环结构作为其极性头基的阳离子胆固醇衍生物的化合物。 这些化合物可用于将生物活性物质递送至细胞并将核酸转染入细胞。

    Lipidic vector for nucleic acid delivery
    38.
    发明授权
    Lipidic vector for nucleic acid delivery 失效
    用于核酸递送的脂质载体

    公开(公告)号:US5908777A

    公开(公告)日:1999-06-01

    申请号:US494296

    申请日:1995-06-23

    CPC分类号: C12N15/88 C07K14/285

    摘要: A simple, rapid method for creating a lipidic vector for delivery of a therapeutic molecule entails bringing the molecule into contact with a polycation, thereby forming a complex, and then mixing the complex with an anionic lipidic preparation. Tissue-specific targeting peptides, fusogenic peptides and nucleus-targeting peptides also can be added to the lipid preparation. The result is a stable lipidic vector of reduced immunogenicity and cytotoxicity. The vector also displays enhanced transfection activity.

    摘要翻译: 用于产生用于递送治疗性分子的脂质载体的简单且快速的方法需要使分子与聚阳离子接触,从而形成复合物,然后将该配合物与阴离子脂质制剂混合。 组织特异性靶向肽,融合肽和核 - 靶向肽也可加入到脂质制剂中。 结果是具有降低的免疫原性和细胞毒性的稳定的脂质载体。 载体还显示增强的转染活性。

    Stable lipid-comprising drug delivery complexes and methods for their
production
    39.
    发明授权
    Stable lipid-comprising drug delivery complexes and methods for their production 失效
    稳定的含脂质药物递送复合物及其生产方法

    公开(公告)号:US5795587A

    公开(公告)日:1998-08-18

    申请号:US376701

    申请日:1995-01-23

    申请人: Xiang Gao Leaf Huang

    发明人: Xiang Gao Leaf Huang

    IPC分类号: A61K9/127 A61K48/00 C12N15/88

    摘要: Novel stable, concentrated, biologically active and ready-to-use lipid-comprising drug delivery complexes and methods for their production are described. The biological activity of the complexes produced are comparable to the formulations prepared according to the prior art admixture method and upon purification, the complexes produced by the method of this invention are 50 to 500 fold more concentrated than the components of the complexes formed by admixture. The method described herein provides for the large scale production of lipid-comprising drug delivery systems useful for gene therapy and other applications.

    摘要翻译: 描述了新的稳定的,浓缩的,生物活性的和即用型含脂质的药物递送复合物及其生产方法。 生产的络合物的生物活性与根据现有技术的混合方法制备的制剂相当,并且在纯化后,通过本发明的方法制备的络合物比通过混合物形成的络合物的组分浓度多50至500倍。 本文所述的方法提供大规模生产用于基因治疗和其它应用的含脂质药物递送系统。

    Treatment of disease states induced by oxidative stress
    40.
    发明授权
    Treatment of disease states induced by oxidative stress 失效
    治疗由氧化应激引起的疾病状态

    公开(公告)号:US5637315A

    公开(公告)日:1997-06-10

    申请号:US349129

    申请日:1994-12-02

    摘要: Liposome carrier systems, methods and pharmaceutical compositions that target an organ preferentially with high concentrations of at least one therapeutic agent utilize a liposome carrier having a lipid membrane and an aqueous space to deliver pharmacologically active agents, such as free radical scavengers and antioxidants, to a target organ such as the liver. At least one free radical scavenger and/or antioxidant and a liposome carrier may be provided to a liver donor prior to harvesting to preserve the liver for transplantation.

    摘要翻译: 优选以高浓度的至少一种治疗剂靶向器官的脂质体载体系统,方法和药物组合物利用具有脂质膜和水性空间的脂质体载体将药理活性剂(例如自由基清除剂和抗氧化剂)递送至 目标器官如肝脏。 可以在收获之前将至少一种自由基清除剂和/或抗氧化剂和脂质体载体提供给肝供体以保留用于移植的肝脏。